Approval · Notice of Compliance 2329 · 2001
REMICADE: Notice of Compliance 2329
Issued September 27, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2329
- Date
- September 27, 2001
- Company
- Centocor Inc.Leiden, --, Netherlands
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Biological response modifier (additional indication: rheumatoid arthritis)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REMICADE | Not yet assigned | — |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL